Gene · 9475
Papers3,801
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
181 to 200 of 3,801
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Therapeutic Advancements in Psoriasis and Psoriatic Arthritis. | J Clin Med | 2025 | 40004842 | PubTator, text mining | PubMed |
| [Progress of researches on acupuncture treatment of spinal cord injury by promoting axonal regeneration]. | Zhen Ci Yan Jiu | 2025 | 39961764 | PubTator, text mining | PubMed |
| Discovery of Dual ROCK1/2 Inhibitors from Nocardiopsis sp. under Metal Stress. | ACS Chem Biol | 2025 | 39893657 | PubTator, text mining | PubMed |
| Pioneering first-in-class HDAC-ROCK inhibitors as potential multitarget anticancer agents. | Future Med Chem | 2025 | 39885716 | PubTator, text mining | PubMed |
| Qiangji decoction mitigates neuronal damage, synaptic and mitochondrial dysfunction in SAMP8 mice through the regulation of ROCK2/Drp1-mediated mitochondrial dynamics. | J Ethnopharmacol | 2025 | 39884484 | PubTator, text mining | PubMed |
| Hepatocyte Rho-associated kinase signaling is required for mice to survive experimental porphyria-associated liver injury. | Hepatol Commun | 2025 | 39878679 | PubTator, text mining | PubMed |
| Discovery of selective ROCK2 inhibitors with free radical scavenging ability for the treatment of gouty arthritis. | Mol Divers | 2025 | 39847187 | PubTator, text mining | PubMed |
| Correction: Investigation of RhoA, ROCK1, and ROCK2 Gene Expressions in Autism Spectrum Disorders. | Cureus | 2025 | 39817265 | PubTator, text mining | PubMed |
| Safety and efficacy of the ROCK-2-inhibitor Belumosudil in cGvHD treatment - a retrospective, German-Swiss multicenter real-world data analysis. | Bone Marrow Transplant | 2025 | 39809902 | PubTator, text mining | PubMed |
| Human parietal epithelial cells as Trojan horses in albumin overload. | Sci Rep | 2025 | 39800742 | PubTator, text mining | PubMed |
| Isoform-selective and non-selective rho-kinase inhibitors do not affect collagenase-induced intracerebral hemorrhage outcomes in mice: Influence of sex and circadian cycle. | J Cereb Blood Flow Metab | 2025 | 39763388 | PubTator, text mining | PubMed |
Corrigendum to "Buyang huanwu decoction inhibits the activation of the RhoA/Rock2 signaling pathway through the phenylalanine metabolism pathway, thereby reducing neuronal apoptosis following cerebral ischemia-reperfusion injury" [J. Ethnopharmacol. 340 (2025) 119246]. | J Ethnopharmacol | 2025 | 39743418 | PubTator, text mining | PubMed |
| NORAD exacerbates metabolic dysfunction-associated steatotic liver disease development via the miR-511-3p/Rock2 axis and inhibits ubiquitin-mediated degradation of ROCK2. | Metabolism | 2025 | 39710000 | PubTator, text mining | PubMed |
| Belumosudil in pediatric patients with chronic graft-versus-host disease after failed multi-line therapy: a case series. | Ann Hematol | 2025 | 39661130 | PubTator, text mining | PubMed |
| Curvature Perception of Mesenchymal Cells on Mesoscale Topographies. | Adv Healthc Mater | 2025 | 39659136 | PubTator, text mining | PubMed |
Polyethylene glycol loxenatide modulates lipid metabolism and insulin resistance through lncRNA steroid receptor RNA activator/cellular nucleic acid binding protein/Rho-associated coiled-coil kinase 2 axis in type 2 diabetes mellitus. | J Diabetes Investig | 2025 | 39651712 | PubTator, text mining | PubMed |
| A study of the role of androgen receptor and androgen receptor variant 7 in TNBC patients and the effect of their targeting by Enzalutamide and EPI-001 in MDA-MB-231. | J Steroid Biochem Mol Biol | 2025 | 39536950 | PubTator, text mining | PubMed |
| Plexin-B2 Mediates Orthodontic Tension-Induced Osteogenesis via the RhoA/F-Actin/YAP Pathway. | J Periodontal Res | 2025 | 39485327 | PubTator, text mining | PubMed |
| MiR-140-3p Normalizes Vascular Smooth Muscle Cell Behavior by Inhibiting the RhoA/ROCK Signaling Pathway in Lower-extremity Arteriosclerosis Obliterans. | Comb Chem High Throughput Screen | 2025 | 38879773 | PubTator, text mining | PubMed |
| In Vitro Experiment Present ROCK2 Inhibition Promotes the Therapeutic Effect of Bevacizumab in the Treatment of Glioblastoma Multiforme. | Clin Neuropharmacol | 2024 | 39792535 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9475/papers?page=10